Targeting the human macrophage with combinations of drugs and inhibitors of Ca2+ and K+ transport to enhance the killing of intracellular multi-drug resistant Mycobacterium tuberculosis (MDR-TB) - a novel, patentable approach to limit the emergence of XDR-TB.

Marta Martins

doi:10.2174/157489111796064524

Targeting the human macrophage with combinations of drugs and inhibitors of Ca2+ and K+ transport to enhance the killing of intracellular multi-drug resistant Mycobacterium tuberculosis (MDR-TB) - a novel, patentable approach to limit the emergence of XDR-TB.

Marta Martins

Unidade de Parasitologia e Microbiologia Médicas (UPMM)

Research output: Contribution to journal › Article › peer-review

11 Citations (Scopus)

Original language	Unknown
Pages (from-to)	110-117
Journal	Recent Patents On Anti-Infective Drug Discovery
Volume	6
Issue number	2
DOIs	https://doi.org/10.2174/157489111796064524
Publication status	Published - 1 Jan 2011

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.2174/157489111796064524

http://www.scopus.com/inward/record.url?partnerID=yv4JPVwI&eid=2-s2.0-79959988742&md5=dabf42802e7c7824ad891854ed063d2c

Cite this

Martins, M. (2011). Targeting the human macrophage with combinations of drugs and inhibitors of Ca2+ and K+ transport to enhance the killing of intracellular multi-drug resistant Mycobacterium tuberculosis (MDR-TB) - a novel, patentable approach to limit the emergence of XDR-TB. Recent Patents On Anti-Infective Drug Discovery, 6(2), 110-117. https://doi.org/10.2174/157489111796064524

@article{22dda83e0f2a420ca21f5b828b44d736,

title = "Targeting the human macrophage with combinations of drugs and inhibitors of Ca2+ and K+ transport to enhance the killing of intracellular multi-drug resistant Mycobacterium tuberculosis (MDR-TB) - a novel, patentable approach to limit the emergence of XDR-TB.",

author = "Marta Martins",

year = "2011",

month = jan,

day = "1",

doi = "10.2174/157489111796064524",

language = "Unknown",

volume = "6",

pages = "110--117",

journal = "Recent Patents On Anti-Infective Drug Discovery",

issn = "1574-891X",

publisher = "Bentham Science Publishers",

number = "2",

}

Martins, M 2011, 'Targeting the human macrophage with combinations of drugs and inhibitors of Ca2+ and K+ transport to enhance the killing of intracellular multi-drug resistant Mycobacterium tuberculosis (MDR-TB) - a novel, patentable approach to limit the emergence of XDR-TB.', Recent Patents On Anti-Infective Drug Discovery, vol. 6, no. 2, pp. 110-117. https://doi.org/10.2174/157489111796064524

Targeting the human macrophage with combinations of drugs and inhibitors of Ca2+ and K+ transport to enhance the killing of intracellular multi-drug resistant Mycobacterium tuberculosis (MDR-TB) - a novel, patentable approach to limit the emergence of XDR-TB. / Martins, Marta.
In: Recent Patents On Anti-Infective Drug Discovery, Vol. 6, No. 2, 01.01.2011, p. 110-117.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Targeting the human macrophage with combinations of drugs and inhibitors of Ca2+ and K+ transport to enhance the killing of intracellular multi-drug resistant Mycobacterium tuberculosis (MDR-TB) - a novel, patentable approach to limit the emergence of XDR-TB.

AU - Martins, Marta

PY - 2011/1/1

Y1 - 2011/1/1

U2 - 10.2174/157489111796064524

DO - 10.2174/157489111796064524

M3 - Article

SN - 1574-891X

VL - 6

SP - 110

EP - 117

JO - Recent Patents On Anti-Infective Drug Discovery

JF - Recent Patents On Anti-Infective Drug Discovery

IS - 2

ER -

Martins M. Targeting the human macrophage with combinations of drugs and inhibitors of Ca2+ and K+ transport to enhance the killing of intracellular multi-drug resistant Mycobacterium tuberculosis (MDR-TB) - a novel, patentable approach to limit the emergence of XDR-TB. Recent Patents On Anti-Infective Drug Discovery. 2011 Jan 1;6(2):110-117. doi: 10.2174/157489111796064524